IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,672 | +10.6% | 588 | 0.0% | 0.00% | +50.0% |
| Q2 2023 | $24,126 | +14.4% | 588 | -0.3% | 0.00% | 0.0% |
| Q1 2023 | $21,087 | +126.0% | 590 | +138.9% | 0.00% | +100.0% |
| Q4 2022 | $9,329 | -28.2% | 247 | -16.8% | 0.00% | -50.0% |
| Q3 2022 | $13,000 | +30.0% | 297 | +12.9% | 0.00% | +100.0% |
| Q2 2022 | $10,000 | 0.0% | 263 | -1.5% | 0.00% | 0.0% |
| Q1 2022 | $10,000 | 0.0% | 267 | -21.5% | 0.00% | 0.0% |
| Q4 2021 | $10,000 | -37.5% | 340 | -27.0% | 0.00% | -50.0% |
| Q3 2021 | $16,000 | +700.0% | 466 | +703.4% | 0.00% | – |
| Q2 2021 | $2,000 | -83.3% | 58 | -78.1% | 0.00% | -100.0% |
| Q1 2021 | $12,000 | -14.3% | 265 | +3.9% | 0.00% | -33.3% |
| Q4 2020 | $14,000 | +133.3% | 255 | +119.8% | 0.00% | +200.0% |
| Q3 2020 | $6,000 | +200.0% | 116 | +182.9% | 0.00% | – |
| Q2 2020 | $2,000 | -91.3% | 41 | -91.6% | 0.00% | -100.0% |
| Q1 2020 | $23,000 | +2200.0% | 490 | +2030.4% | 0.00% | – |
| Q4 2019 | $1,000 | -91.7% | 23 | -89.4% | 0.00% | -100.0% |
| Q3 2019 | $12,000 | +1100.0% | 218 | +847.8% | 0.00% | – |
| Q2 2019 | $1,000 | -98.1% | 23 | -96.6% | 0.00% | -100.0% |
| Q1 2019 | $53,000 | +5200.0% | 676 | +2839.1% | 0.01% | – |
| Q4 2018 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 23 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 23 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | – | 23 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 23 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $1,000 | -50.0% | 23 | -74.7% | 0.00% | 0.0% |
| Q1 2016 | $2,000 | -80.0% | 91 | -49.2% | 0.00% | -85.7% |
| Q4 2015 | $10,000 | – | 179 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |